UBS AM’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37B | Buy |
|
|||||
|
2025
Q1 | $1.24B | Buy |
|
|||||
|
2024
Q4 | $938M | Sell |
|
|||||
|
2024
Q3 | $1.14B | Sell |
|
|||||
|
2024
Q2 | $1.21B | Buy |
|
|||||
|
2024
Q1 | $1.02B | Sell |
|
|||||
|
2023
Q4 | $1.06B | Sell |
|
|||||
|
2023
Q3 | $965M | Sell |
|
|||||
|
2023
Q2 | $886M | Hold |
|
|||||
|
2023
Q1 | $886M | Sell |
|
|||||
|
2022
Q4 | $846M | Sell |
|
|||||
|
2022
Q3 | $915M | Buy |
|
|||||
|
2022
Q2 | $880M | Sell |
|
|||||
|
2022
Q1 | $819M | Sell |
|
|||||
|
2021
Q4 | $772M | Buy |
|
|||||
|
2021
Q3 | $500M | Buy |
|
|||||
|
2021
Q2 | $494M | Buy |
|
|||||
|
2021
Q1 | $445M | Sell |
|
|||||
|
2020
Q4 | $493M | Buy |
|
|||||
|
2020
Q3 | $439M | Buy |
|
|||||
|
2020
Q2 | $451M | Buy |
|
|||||
|
2020
Q1 | $334M | Buy |
|
|||||
|
2019
Q4 | $297M | Sell |
|
|||||
|
2019
Q3 | $235M | Sell |
|
|||||
|
2019
Q2 | $256M | Buy |
|
|||||
|
2019
Q1 | $250M | Sell |
|
|||||
|
2018
Q4 | $225M | Buy |
|
|||||
|
2018
Q3 | $255M | Sell |
|
|||||
|
2018
Q2 | $231M | Buy |
|
|||||
|
2018
Q1 | $201M | Sell |
|
|||||
|
2017
Q4 | $186M | Buy |
|
|||||
|
2017
Q3 | $170M | Sell |
|
|||||
|
2017
Q2 | $151M | Sell |
|
|||||
|
2017
Q1 | $149M | Sell |
|
|||||
|
2016
Q4 | $165M | Sell |
|
|||||
|
2016
Q3 | $242M | Sell |
|
|||||
|
2016
Q2 | $239M | Sell |
|
|||||
|
2016
Q1 | $235M | Buy |
|
|||||
|
2015
Q4 | $365M | Sell |
|
|||||
|
2015
Q3 | $324M | Sell |
|
|||||
|
2015
Q2 | $399M | Buy |
|
|||||
|
2015
Q1 | $326M | Buy |
|
|||||
|
2014
Q4 | $173M | Buy |
|
|||||
|
2014
Q3 | $151M | Buy |
|
|||||
|
2014
Q2 | $126M | Sell |
|
|||||
|
2014
Q1 | $96.9M | Buy |
|
|||||
|
2013
Q4 | $88.6M | Buy |
|
|||||
|
2013
Q3 | $87.1M | Buy |
|
|||||
|
2013
Q2 | $77.8M | Buy |
|